Mouse CCR2 shRNA Plasmid: Gene Silencing and Monocyte Migration Research

Explore the role of the mouse CCR2 chemokine receptor in immune-cell trafficking, inflammation and RNA interference research.

Introduction to CCR2 and RNA Interference

The C-C motif chemokine receptor 2 (CCR2) is a G protein-coupled receptor involved in the movement and recruitment of monocytes and other immune cells. It responds to chemokines including CCL2, also known as monocyte chemoattractant protein-1 (MCP-1), and helps regulate the migration of inflammatory monocytes toward tissues.

Because CCR2 participates in immune-cell trafficking, it is an important research target in studies of inflammation, tissue injury, immune responses and disease models.

RNA interference (RNAi) provides a way to investigate gene function by reducing the expression of a selected target. Short hairpin RNA (shRNA) is an RNA molecule designed to be processed by cellular machinery into small interfering RNA, which can guide the degradation of complementary messenger RNA.

What Is the Function of Mouse CCR2?

Mouse CCR2, encoded by the Ccr2 gene, is a chemokine receptor expressed by specific immune-cell populations, particularly monocytes. Its interaction with chemokine ligands contributes to the regulation of cell migration from the bone marrow into circulation and toward sites of inflammation.

Experimental studies in CCR2-deficient mice have demonstrated impaired monocyte recruitment in inflammatory models. These findings established the importance of CCR2-mediated signaling in the regulation of immune-cell movement.

How Does CCR2 shRNA Work?

shRNA is commonly used in gene-silencing experiments to reduce the expression of a target gene. Following expression and processing inside a suitable cellular system, shRNA-derived small interfering RNA can associate with the RNA-induced silencing complex (RISC).

The complex recognizes complementary target messenger RNA and promotes its degradation, potentially reducing the amount of the corresponding protein produced by the cell.

The effectiveness of an shRNA experiment depends on factors such as target sequence, delivery method, cell type, expression conditions and experimental controls. Knockdown should be confirmed experimentally rather than assumed from plasmid use alone.

Research Applications of Mouse CCR2 Gene Silencing

CCR2-targeted RNA interference can support experimental investigations into the biological role of this receptor. Potential research areas include:

Experimental Considerations for shRNA Studies

Reliable RNAi experiments require appropriate experimental design and validation. Researchers commonly consider the following elements:

• Appropriate controls: Include suitable non-targeting shRNA and untreated or mock-treated controls.
• Gene-expression analysis: Assess target mRNA levels using an appropriate method, such as RT-qPCR.
• Protein-level validation: Where appropriate, evaluate CCR2 protein expression using a validated protein detection method.
• Cellular effects: Monitor cell viability and relevant phenotypic changes.
• Specificity: Consider potential off-target effects and use independent validation strategies when possible.

These considerations help distinguish specific CCR2-related effects from experimental variability or unintended gene-silencing effects.

Research use only. Please consult the product documentation for sequence information, recommended experimental conditions and other technical details.

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Conclusion

CCR2 is an important regulator of monocyte trafficking and inflammatory-cell recruitment. RNA interference offers researchers a useful approach for investigating the contribution of this chemokine receptor to immune-cell behavior and inflammatory mechanisms.

The Mouse CCR2 shRNA Plasmid is listed for RNAi research applications and may be considered for studies investigating mouse CCR2 gene function. Appropriate controls and experimental validation are essential when interpreting gene-silencing results.

Scientific References

1. Boring L. et al. (1997). Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. Journal of Clinical Investigation, 100(10), 2552–2561. Read scientific article.
2. Kuziel W.A. et al. (1997). Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proceedings of the National Academy of Sciences. Read scientific article.
3. Berkel T.J.C. van et al. (2005). Lentiviral shRNA silencing of murine bone marrow cell CCR2 leads to persistent knockdown of CCR2 function in vivo. Blood, 106(4), 1147–1153. Read scientific article.
4. Leuschner F. et al. (2011). Therapeutic siRNA silencing in inflammatory monocytes. Nature Biotechnology, 29, 1005–1010. Read scientific article.

This article is intended for scientific and educational purposes. The product is for research use only and is not intended for diagnostic or therapeutic use.